4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-040694
CEO sold 4,767 shares at $15.47 ($73,750)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shah Gaurav CEO | 2023-08-17 | Sale | −4,767 | $15.47 | $73,750 | 524,854 | D: show line 1 in the form |
| Open-market sales · 4,767 sh · avg $15.47 · $73,750 | |||||||
Loading xslF345X05/form4.xml…